Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansRhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancerConcurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasisSrc phosphorylation of RhoGDI2 regulates its metastasis suppressor function.A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasisIdentification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cellsMolecular substratification of bladder cancer: moving towards individualized patient managementOncosuppressive functions of decorinStimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer typesUnderstanding the molecular pathogenesis and prognostics of bladder cancer: an overviewNormal and neoplastic urothelial stem cells: getting to the root of the problemInsidious changes in stromal matrix fuel cancer progressionCoordination of nutrient availability and utilization by MAX- and MLX-centered transcription networksA role for G-CSF and GM-CSF in nonmyeloid cancersEmerging critical role of molecular testing in diagnostic genitourinary pathologyRAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expressionComplete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeOverlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer modelA Myc network accounts for similarities between embryonic stem and cancer cell transcription programsAn embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumorsPatient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.A gene expression ratio-based diagnostic test for bladder cancerUse of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents.Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat.A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryMetastasis suppressor proteins: discovery, molecular mechanisms, and clinical applicationPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors.Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma.
P2860
Q21710680-63DB9546-E932-49EE-80DA-E2127D78BB11Q24608385-42D7C930-3DE7-4C4F-8795-874CBF707679Q24623746-71CFC437-5895-4D0A-997C-0946AE0FCA8EQ24630230-4AC80D7E-876B-4FE7-8044-800E084F7758Q24645336-DD5B0D63-402E-4C73-A591-5B8F295A39ABQ24649156-364F38A5-7D1D-4526-AD7C-DF1E5D7D553FQ24657020-2D003293-1C8C-4EC8-B258-A89EF692DE4AQ26744343-AF32EFC0-E139-46B6-8650-318EF574EFEFQ26745697-9AAB05D7-7C1A-4C78-B6EE-C37F570D6FD1Q26745894-F1496955-2D19-4FAF-AC8E-95B3DA62921EQ26752921-851ACD4D-43FC-45B6-8ECA-55EAED20AFA6Q26825948-B53B743F-445E-40E8-ABEC-67B0D40CBF2BQ26851261-255BB126-DA50-40A9-83FF-1987D427ECDFQ26853482-F6457EFB-F2D1-4975-9AD7-9BDE9550A0B7Q27002515-D66BE171-79AF-4A66-BE9A-1014BBB5E3C8Q27021371-C407CBE2-4B77-48AE-A193-41445B1D0145Q27320277-12EE16E6-EDF2-48A9-B7B4-49A9A9AC7C2CQ27853334-35EB103E-7E49-4DF7-865C-2F577A6FAB8DQ28273187-C9203E1F-3E6E-4D61-86BE-C8855E82EECAQ28291731-D804124C-B9B7-4BC7-9744-7C3BC3B86DD3Q28477425-98F92A9D-37A1-42B2-B5EB-9AE5372FCB02Q28507017-ED0FA0E4-0A60-4B1E-ADF3-303F84814125Q29615393-69AC5B5B-0C56-42EF-B539-8B7636E4BE32Q30279180-DD0D1A0C-F043-442F-B3A3-DF6E1DCFD38EQ30301104-56A2B4D8-852D-4A53-AE15-329DDEF99841Q30408466-1E697366-D55A-45EF-B248-9D1C82296E8EQ30408689-980944AA-2666-4EE3-A85E-B47775980CC8Q30416201-A4C3CB8B-8549-4DA4-A0E9-BB39DE0D453AQ30421675-810C3D02-2CD6-4E74-B0A1-C79BF4594291Q30422907-C0684BAB-BDD6-40E1-94A0-A80A86DCA3AFQ30430715-7E5FFFD5-CF9A-4960-90A5-38A781B4D4A8Q30433465-7B226594-870D-43FF-B06A-86119A723A29Q30434237-C6AF8F44-65EF-4E98-988E-25CDF9CF36DAQ30437629-3E7EFEFA-4523-4F78-B15D-F899893BF5E5Q30443764-0D9802BA-42EA-46D4-9BD4-0A8E020A4020Q30444715-BF70C1B1-87EE-4AB5-8B91-1557589156F1Q30446429-481F7B6B-2A07-4742-8443-E96A86D64287Q30459452-FD9E80EE-886F-4E6A-AC3A-89C0A308BB4EQ30485127-10DFA062-B5A2-4147-BEC6-D3DDDD3A52CEQ30485940-A3B324F6-539F-4969-80BD-A5E72A26D91F
P2860
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Defining molecular profiles of ...... g oligonucleotide microarrays.
@en
Defining molecular profiles of ...... g oligonucleotide microarrays.
@nl
type
label
Defining molecular profiles of ...... g oligonucleotide microarrays.
@en
Defining molecular profiles of ...... g oligonucleotide microarrays.
@nl
prefLabel
Defining molecular profiles of ...... g oligonucleotide microarrays.
@en
Defining molecular profiles of ...... g oligonucleotide microarrays.
@nl
P2093
P356
P1476
Defining molecular profiles of ...... g oligonucleotide microarrays.
@en
P2093
Fabien Saint
Juanjo Lozano
Marta Sanchez-Carbayo
Nicholas D Socci
P304
P356
10.1200/JCO.2005.03.2375
P407
P577
2006-01-23T00:00:00Z